Company
F-Prime Capital
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Flourish Health | Series A | 2026-07-28 | Lead |
| Countable Labs | Funding | 2026-05-28 | |
| Canary Technologies | Series D | 2025-06-13 | |
| Atalanta Therapeutics | Series B | 2025-01-28 | |
| 1Money | Funding | 2025-01-16 | |
| Tenvie Therapeutics | Funding | 2025-01-08 | Lead |
| nChroma Bio | Financing | 2024-12-12 | |
| Quantum Circuits | Series B Funding | 2024-08-16 | Lead |
| RareCyte | Financing | 2024-06-27 | Lead |
| Canary Technologies | Series C Funding | 2024-06-12 | |
| Expressable | series b | 2024-05-21 | |
| Engrail Therapeutics | Series B Financing | 2024-03-19 | Lead |
| HiLabs | Series B Funding | 2024-03-14 | |
| Nocion Therapeutics Extends Series B Financing to $93M | Series B Financing | 2024-03-06 | |
| Burro | Series B | 2024-01-09 | |
| Adela | Financing | 2023-09-26 | |
| Better Life Partners | Series B Financing | 2023-08-29 | Lead |
| Albert Invent | Seed Funding | 2023-06-14 | |
| Bicara Therapeutics | Series B Financing | 2023-03-06 | |
| Canoe Intelligence | Series B | 2023-02-08 | Lead |
| Nocd | Funding | 2023-02-01 | |
| Paradigm | Series A | 2023-01-30 | |
| Canary Technologies | Series B | 2022-10-28 | |
| Neumora Therapeutics | Series B | 2022-10-11 | Lead |
| Rippl | Seed | 2022-09-28 | |
| RightHand Robotics | Series C | 2022-02-23 |